International Health Regulations—What Gets Measured Gets Done
نویسندگان
چکیده
منابع مشابه
International Health Regulations—What Gets Measured Gets Done
The global spread of severe acute respiratory syndrome highlighted the need to detect and control disease outbreaks at their source, as envisioned by the 2005 revised International Health Regulations (IHR). June 2012 marked the initial deadline by which all 194 World Health Organization (WHO) member states agreed to have IHR core capacities fully implemented for limiting the spread of public he...
متن کاملSoftware Process Improvement: What gets measured gets done
A software quality management system (QMS) has been designed in a democratic fashion by programmers and has been approved by management. In order to motivate the programmers in following their own standards, measurement feedback is used for creating social pressure (peer pressure and management pressure). In nine out of ten cases this approach has been successful. Could the failure of the tenth...
متن کاملWhat Gets Measured Gets Done: An Assessment of Local Data Uses and Needs in Large Urban Health Departments
CONTEXT The epidemiologic shift in the leading causes of mortality from infectious disease to chronic disease has created significant challenges for public health surveillance at the local level. OBJECTIVE We describe how the largest US city health departments identify and use data to inform their work and we identify the data and information that local public health leaders have specified as...
متن کامل‘What gets measured gets managed’: revisiting the indicators for maternal and newborn health programmes
BACKGROUND The health of women and children are critical for global development. The Sustainable Development Goals (SDG) agenda and the Global Strategy for Women's, Children's, and Adolescent's Health 2016-2030 aim to reduce maternal and newborn deaths, disability, and enhancement of well-being. However, information and data on measuring countries' progress are limited given the variety of meth...
متن کاملRedefining how pharmaceutical innovation gets done
The productivity of research and development in the bio-pharmaceutical industry has been constantly declining since the early 2000's. One possible reason is that biomedical projects are risky, take a long time, and require significant investment. Hence, substantial capital has been shifted away from the bio-pharmaceutical industry to other industries that are perceived less risky, creating a fu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Emerging Infectious Diseases
سال: 2012
ISSN: 1080-6040,1080-6059
DOI: 10.3201/eid1807.120487